Differential electrophysiological actions of endothelin-1 on Cl- and K+ currents in myocytes isolated from aorta, basilar and pulmonary artery

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 3, 1998, Pages 1122-1131

  Salter, Katie J ^a   Kozlowski, Roland Z ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; AMPHOTERICIN B; ENDOTHELIN 1;

ANIMAL CELL; ARTICLE; BASILAR ARTERY; CHLORIDE CURRENT; DRUG EFFECT; DRUG RECEPTOR BINDING; ELECTROPHYSIOLOGY; ENDOTHELIUM CELL; EVOKED RESPONSE; HEART MUSCLE CELL; ION EXCHANGE; LIGAND BINDING; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; VASCULAR SMOOTH MUSCLE; VOLTAGE CLAMP;

ANIMALS; AORTA; BASILAR ARTERY; CALCIUM; CHLORIDE CHANNELS; ENDOTHELIN-1; MALE; MEMBRANE POTENTIALS; MUSCLE, SMOOTH, VASCULAR; POTASSIUM CHANNELS; PULMONARY ARTERY; RATS; RECEPTORS, ENDOTHELIN;

EID: 0031909836     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Arai H, Hori S, Aramori I, Ohkubo H and Nakashi S (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730-732.
2. Aramori I, Nirei H, Shoubo M, Sogabe K, Nakamura K, Kojo H, Notsu Y, Ono T and Nakanishi S (1993) Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in Chinese hamster ovary cells. Mol Pharmacol 43:127-131.
3. + currents in arterial myocytes. Biochem Biophys Res Commun 227:168-175.
4. Barnes PJ (1994) Endothelins and pulmonary diseases. J Appl Physiol 73:1051-1059.
5. Brown CDA and Dudley AJ (1996) Chloride channel blockers decrease intracellular pH in cultured renal epithelial LLC-PK-1 cells. Br J Pharmacol 118:443-444.
6. Chen C and Wagoner PK (1991) Endothelin induces a nonselective cation current in vascular smooth muscle cells. Circ Res 69:447-454.
7. - currents in pulmonary arterial myocytes. Am J Physiol 270:H1577-H1584.
8. Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Gray GA, Hirth G, Loffler BM, Muller M, Neidhart W and Ramuz H (1993) Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365:759-761.
9. Douglas SA, Meek TD and Ohlstein EH (1994) Novel receptor antagonists welcome new era in endothelin biology. Trends Pharmacol Sci 15:313-316.
10. Enoki T, Miwa S, Sakamoto A, Minowa T, Komuro T, Kobayashi S, Ninomiya H and Masaki T (1995) Long-lasting activation of cation current by low concentration of endothelin-1 in mouse fibroblasts and smooth muscle cells of rabbit aorta. Br J Pharmacol 115:479-485.
11. Fukuroda T, Kobayashi M, Ozaki S, Yano M, Miyauchi T, Onizuka M, Sugishita Y, Goto K and Nishikibe M (1994) Endothelin receptor subtypes in human versus rabbit pulmonary arteries. J Appl Physiol 76:1976-1982.
12. Galvez A, Gimenez-Gallego G, Reuben JP, Roy-Contancin L, Feigenbaum P, Kaczorowski GJ and Garcia ML (1990) Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem 265:11083-11090.
13. Gogelein H, Dahlem D, Englert HC and Lang HJ (1990) Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreas. FEBS Lett 268:79-82.
14. 2+ channel in vascular smooth muscle. Proc Natl Acad Sci USA 86:3915-3918.
15. Greenwood IA and Large WA (1995) Comparison of the effects of fenamates on Ca-activated chloride and potassium currents in portal vein smooth muscle cells. Br J Pharmacol 116:2939-2948.
16. + channel activity in isolated rat arterial smooth muscle cells. Biochim Biophys Acta 1283: 192-198.
17. Hogg RC, Wang Q and Large WA (1994) Action of niflumic acid on evoked and spontaneous calcium-activated chloride and potassium currents in smooth muscle cells from rabbit portal vein. J Physiol 112:977-984.
18. Horn R and Marty A (1988) Muscarinic activation of ionic currents measured by a new whole-cell recording method. J Gen Physiol 92:145-159.
19. + channel in smooth muscle cells of porcine coronary artery. Eur J Pharmacol 194:31-36.
20. Kai H, Kanaide H and Nakamura M (1989) Endothelin-sensitive intracellular calcium store overlaps with caffeine-sensitive one in rat aortic smooth muscle cells in primary culture. Biochem Biophys Res Commun 158:235-243.
21. Kirkup AJ, Edwards G, Green ME, Miller M, Walker SD and Weston AH (1996) Modulation of membrane currents and mechanical activity by niflumic acid in rat vascular smooth muscle. Eur J Pharmacol 317:165-174.
22. 2+ currents in cardiac myocytes. Am J Physiol 250:35-42.
23. Leach RM, Twort CHC, Cameron IR and Ward JPT (1990) The mechanism of action of endothelin-1 on small pulmonary arterial vessels. Pulm Pharmacol 3:103-109
24. Lembeck F, Decrinis M, Pertl C, Amann R and Donnerer J (1989) Effects of endothelin on the cardiovascular system and on smooth muscle preparations in different species. Naunyn-Schmiedeberg's Arch Pharmacol 340:744-751.
25. Matsuyama K, Yasue H, Okumura K, Saito Y, Nakao K, Shirakami G and Imura H (1991) Increased plasma level of endothelin-1-like immunoreactivity during coronary spasm in patients with coronary spastic angina. Am J Cardiol 68:991-995
26. + channels and depolarizes smooth muscle cell of porcine coronary artery. Circ Res 70:612-616.
27. 2+ influx. J Mol Cell Cardiol 28:707-722.
28. Ottolia M and Toro L (1994) Potentiation of large conductance KCa channels by niflumic, flufenamic and mefenamic acids. Biophys J 67:2272-2279.
29. Panek RL, Major TC, Hingorani GP, Doherty AM, Taylor DG and Rapundalo ST (1992) Endothelin and structurally related analogs distinguish between endothelin receptor subtypes. Biochem Biophys Res Commun 183:566-571.
30. Poronnik P, Ward MC and Cook DI (1992) Intracellular calcium release by flufenamic acid and other blockers of the non-selective cation channel. FEBS Lett 296:245-248.
31. Rubanyi GM and Polokoff MA (1994) Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46:325-415.
32. Sakata K, Ozaki H, Kwon S-C and Haraki H (1989) Effects of endothelin on the mechanical activity and cytosolic calcium levels of various types of smooth muscle. Br J Pharmacol 98:483-492.
33. Sokurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K and Masaki T (1990) Cloning of cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732-735.
34. Salter KJ and Kozlowski RZ (1996) Endothelin receptor coupling to potassium and chloride channels in isolated rat pulmonary arterial myocytes. J Pharmacol Exp Ther 279:1053-1062.
35. Shigeno T, Clozel M, Sakai S, Saito A and Goto K (1995) The effect of bosentan, a new endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm. Neurosurgery. 37:87-91.
36. Stewart DJ, Levy RD, Cernacek P and Langleben D (1991) Increased plasma endothelin-1 levels in pulmonary hypertension. Marker or mediator of disease? Ann Intern Med 114:464-469.
37. Sudjarwo SA, Hori M, Takai M, Urade Y, Okada T and Karaki H (1993) A novel subtype of endothelin B receptor mediating contraction in swine pulmonary vein. Life Sci 53:431-437.
38. Sugiura N, Inagami T, Hare GM and Johns JA (1989) Endothelin action: Inhibition by a protein kinase C inhibitor and involvement of phosphoinositols. Biochem Biophys Res Commun 158:170-176.
39. B receptors mediate vascular smooth muscle contraction. Br J Pharmacol 107:858-860.
40. Suzuki H, Sato S, Suzuki Y, Oka M, Tsuchiya T, Iino I, Yamanaka T, Ishihara N and Shimoda SI (1990) Endothelin immunoreactivity in cerebrospinal fluid of patients with subarachnoid hemorrhage. Ann Med 22:233-236.
41. Toyo-Oka T, Aizawa T, Suzuki N, Hirata Y, Miyauchi T, Shin WS, Yanagisawa M, Masaki T and Sugimoto T (1991) Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 83:476-483.
42. Toyo-Oka T and Sugimoto T (1991) Editorial comment: endothelin: Key to coronary vasospasm? Circulation 84:1451-1452.
43. Van Renterghem CP, Vigne P, Barhanin J, Schmid-Alliana A, Frelin C and Lazdunski M (1988) Molecular mechanism of action of the vasoconstrictor peptide endothelin. Biochem Biophys Res Commun 157:977-985.
44. Warner TD, Allcock GH, Corder R and Vane JR (1993) Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Br J Pharmacol 10:777-782.
45. Williams DL, Jones KL, Pettibone DJ, Lis EV and Clineschmidt BV (1991) Sarfotoxin S6c: An agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 175:556-561.
46. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Goto K and Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415.